| Literature DB >> 34771125 |
David Fonseca-Hernández1, Eugenia Del Carmen Lugo-Cervantes1, Antonio Escobedo-Reyes1, Luis Mojica1.
Abstract
Phenolic compounds present in common beans (Phaseolus vulgaris L.) have been reported to possess antimicrobial, anti-inflammatory and ultraviolet radiation (UVR) protective properties. UVR from sunlight, which consists of UV-B and UV-A radiations, induces reactive oxygen species (ROS) and free radical formation, consequently activating proteinases and enzymes such as elastase and tyrosinase, leading to premature skin aging. The objective of this work was to extract, characterize and evaluate the antioxidant and antiaging potential of polyphenols from a black bean endemic variety. The polyphenolic extract was obtained from black beans by supercritical fluid extraction (SFE) using CO2 with a mixture of water-ethanol as a cosolvent and conventional leaching with a mixture of water-ethanol as solvent. The polyphenolic extracts were purified and characterized, and antioxidant potential, tyrosinase and elastase inhibitory potentials were measured. The extract obtained using the SFE method using CO2 and H2O-Ethanol (50:50 v/v) as a cosolvent showed the highest total phenolic compounds yield, with 66.60 ± 7.41 mg GAE/g coat (p > 0.05) and 7.30 ± 0.64 mg C3GE/g coat (p < 0.05) of anthocyanins compared to conventional leaching. Nineteen tentative phenolic compounds were identified in leaching crude extract using ESI-QTOF. Quercetin-3-D-galactoside was identified in crude and purified extracts. The purified SFC extract showed IC50 0.05 ± 0.002 and IC50 0.21 ± 0.008 mg/mL for DPPH and ABTS, respectively. The lowest IC50 value of tyrosinase inhibition was 0.143 ± 0.02 mg/mL and 0.005 ± 0.003 mg/mL of elastase inhibition for leaching purified extract. Phenolic compounds presented theoretical free energy values ranging from -5.3 to -7.8 kcal/mol for tyrosinase and -2.5 to -6.8 kcal/mol for elastase in molecular docking (in silico) studies. The results suggest that the purified extracts obtained by SFE or conventional leaching extraction could act as antioxidant and antiaging ingredients for cosmeceutical applications.Entities:
Keywords: antioxidant; black bean; elastase; phenolic compounds; supercritical fluids extraction; tyrosinase
Mesh:
Substances:
Year: 2021 PMID: 34771125 PMCID: PMC8587475 DOI: 10.3390/molecules26216716
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Total phenolic compounds and anthocyanins extracts obtained by SFE and leaching process.
| Extraction Method | Cosolvent | Total Phenolic Compounds (mg GAE/g Coat) | Anthocyanins (mg C3GE/g Coat) |
|---|---|---|---|
| SFE | H2O-100% | 63.77 ± 3.16 a | 6.76 ± 0.37 a |
| SFE | H2O-EtOH 50% | 66.60 ± 7.41 a | 7.30 ± 0.64 a |
| Leaching | H2O-100% | 44.04 ±1.39 b | 3.50 ± 0.35 b |
| Leaching | H2O-EtOH 50% | 59.83 ± 4.86 a | 5.87 ± 0.21 c |
SFE: supercritical fluid extraction, EtOH: ethanol, H2O: water, C3GE: Cyanidin 3-glucoside equivalents, GAE: gallic acid equivalents. Different letters indicate significant differences within a column at p < 0.05 (Tukey HSD post hoc analysis).
Tentative phenolic compounds identified by ESI-QTOF using direct infusion analysis.
| Sample | Tentative Identification | Elemental Formula Compound | Ion | Tentative Error ppm | ||
|---|---|---|---|---|---|---|
| Leaching Crude Extract | Quercetin-3-D-Galactoside | C21H20O12 | [M-H]− | 463.1211 | 463.1211 * | 0 |
| Malvidin-3-Glucoside | C23H25O12 | [M+H]+ | 331.0715 | 331.0641 * | −22.3 | |
| Delphinidin 3-Glucoside | C21H20O12 | [M+H]+ | 303.0402 | 303.0402 * | 0 | |
| Cyanidin 3-Glucoside | C21H21O11+ | [M-H]− | 447.1285 | 447.1242 * | −9.61 | |
| Petunidin-3-O-β-Glucoside | C22H23O12 | [M-H]− | 447.1285 | 447.1033 | - | |
| Gallic acid | C7H6O5 | [M-H]− | 169.0686 | 169.0606 | - | |
| Sinapic acid | C11H12O5 | [M-H]− | 223.0993 | 223.0607 | - | |
| Genistein | C15H10O5 | [M-H]− | 269.021 | 269.0455 | - | |
| Protocatechuic acid | C7H6O4 | [M-H]− | 153.0649 | 153.0188 | - | |
| Rutin | C27H30O16 | [M-H]− | 609.1525 | 609.1461 | - | |
| Naringenin | C15H12O5 | [M-H]− | 271.0737 | 271.0612 | - | |
| Catechin | C15H14O6 | [M-H]− | 289.1219 | 289.0712 | - | |
| Glycitein | C16H12O5 | [M+H]+ | 285.0356 | 285.0749 | - | |
| Myricetin | C15H10O8 | [M-H]− | 317.0705 | 317.0303 | - | |
| Ferulic acid | C10H10O4 | [M-H]− | 193.0635 | 193.0506 | - | |
| Daidzin | C21H20O9 | [M-H]− | 415.09 | 415.1 | - | |
| p-coumaric acid | C9H8O3 | [M-H]− | 163.1649 | 163.0395 | - | |
| Caffeic acid | C15H10O4 | [M-H]− | 179.1075 | 179.0345 | - | |
| Rosmarinic acid | C18H16O8 | [M-H]− | 359.1975 | 359.0767 | - | |
| Leaching Pure Extract | Quercetin-3-D-Galactoside | C21H20O12 | [M-H]− | 463.1255 | 463.1211 * | −9.5 |
| Malvidin-3-Glucoside | C23H25O12 | [M+H]+ | 331.0715 | 331.0641 * | −22.3 | |
| Delphinidin 3-Glucoside | C21H20O12 | [M+H]+ | 303.0438 | 303.0402 * | −11.8 | |
| Cyanidin 3-Glucoside | C21H21O11+ | [M-H]− | 447.1328 | 447.1242 * | −9.61 | |
| Petunidin-3-O- β -Glucoside | C22H23O12 | [M-H]− | 447.1422 | 447.1033 | - | |
| Gallic acid | C7H6O5 | [M-H]− | 169.0713 | 169.0606 | - | |
| Protocatechuic acid | C7H6O4 | [M-H]− | 153.07 | 153.0188 | - | |
| Rutin | C27H30O16 | [M-H]− | 609.1423 | 609.1461 | - | |
| Naringenin | C15H12O5 | [M-H]− | 271.0737 | 271.0612 | - | |
| Rosmarinic acid | C18H16O8 | [M-H]− | 359.2091 | 359.0767 | - | |
| Catechin | C15H14O6 | [M-H]− | 289.1184 | 289.0712 | - | |
| Glycitein | C16H12O5 | [M+H]+ | 285.0356 | 285.0749 | - | |
| Myricetin | C15H10O8 | [M-H]− | 317.0823 | 317.0303 | - | |
| Ferulic acid | C10H10O4 | [M-H]− | 193.1005 | 193.0506 | - | |
| SFE Crude Extract | Quercetin-3-D-Galactoside | C21H20O12 | [M-H]− | 463.0462 | 463.0876 * | 89.4 |
| Cyanidin 3-Glucoside | C21H21O11+ | [M-H]− | 447.0592 | 447.1242 * | 145.3 | |
| Gallic acid | C7H6O5 | [M-H]− | 169.0207 | 169.0606 | - | |
| Caffeic acid | C15H10O4 | [M-H]− | 179.0829 | 179.0345 | - | |
| Daidzin | C21H20O9 | [M-H]− | 415.0513 | 415.1 | - | |
| Sinapic acid | C11H12O5 | [M-H]− | 223.0014 | 223.0607 | - | |
| Naringenin | C15H12O5 | [M-H]− | 271.0333 | 271.0612 | - | |
| Rosmarinic acid | C18H16O8 | [M-H]− | 359.1432 | 359.0767 | - | |
| Catechin | C15H14O6 | [M-H]− | 289.0766 | 289.0712 | - | |
| Myricetin | C15H10O8 | [M-H]− | 317.0568 | 317.0303 | - | |
| Ferulic acid | C10H10O4 | [M-H]− | 193.0436 | 193.0506 | - | |
| SFE Pure Extract | Quercetin-3-D-Galactoside | C21H20O12 | [M-H]− | 463.0462 | 463.0872 * | 89.4 |
| Cyanidin 3-Glucoside | C21H21O11+ | [M-H]− | 447.0679 | 447.1242 * | 125.9 | |
| Gallic acid | C7H6O5 | [M-H]− | 169.0367 | 169.0606 | - | |
| Caffeic acid | C15H10O4 | [M-H]− | 179.0801 | 179.0345 | - | |
| Daidzin | C21H20O9 | [M-H]− | 415.06 | 415.1 | - | |
| Sinapic acid | C11H12O5 | [M-H]− | 223.0443 | 223.0607 | - | |
| Naringenin | C15H12O5 | [M-H]− | 271.0333 | 271.0612 | - | |
| Rosmarinic acid | C18H16O8 | [M-H]− | 359.1432 | 359.0767 | - | |
| Catechin | C15H14O6 | [M-H]− | 289.0662 | 289.0712 | - | |
| Myricetin | C15H10O8 | [M-H]− | 317.0239 | 317.0303 | - | |
| Ferulic acid | C10H10O4 | [M-H]− | 193.0721 | 193.0506 | - |
SFE: Supercritical fluid extraction, * symbol indicates the theoretical m/z obtained with pure standards, while theoretical m/z without the symbol was obtained from MoNa-Mass Bank of North America (https://mona.fiehnlab.ucdavis.edu/) (accessed on 7 July 2021), tentative error ppm was calculated only for the compounds identified with pure standards.
Figure 1DPPH antioxidant capacity analysis. Purified extracts (A), crude extracts (B). The results are shown as mean ± standard error. Different letters indicate significant differences among treatments (p < 0.05) (Tukey’s HSD post hoc analysis).
Figure 2ABTS antioxidant capacity analysis. Purified extracts (A), crude extracts (B). The results are shown as mean ± standard error. Different letters indicate significant differences among treatments (p < 0.05) (Tukey’s HSD post hoc analysis).
Figure 3Tyrosinase inhibition capacity analysis. Purified extracts (A), crude extracts (B). The results are shown as mean ± standard error. Different letters indicate significant differences among treatments (p < 0.05) (Tukey’s HSD post hoc analysis).
Figure 4Elastase inhibition capacity analysis. Purified extracts (A), crude extracts (B). The results are shown as mean ± standard error. Different letters indicate significant differences among treatments (p < 0.05) (Tukey’s HSD post hoc analysis).
Molecular docking analysis.
| Phenolic Compounds Identified | Predicted Binding Affinity | |
|---|---|---|
| Tyrosinase | Elastase | |
| Quercetin-3-D-Galactoside | −7.6 | −4.8 |
| Malvidin-3-Glucoside | −7.8 | −5.5 |
| Delphinidin-3-Glucoside | −7.1 | −5.8 |
| Cyanidin-3-Glucoside | −7.7 | −3.4 |
| Petunidin-3-O-β-Glucoside | −7.7 | −5.7 |
| Gallic acid | −5.9 | −5.7 |
| Sinapic acid | −5.9 | −4.7 |
| Genistein | −6.9 | −5.6 |
| Protocatechuic acid | −5.8 | −5.3 |
| Rutin | −8.5 | −2.4 |
| Naringenin | −6.8 | −6.7 |
| Catechin | −6.8 | −6.9 |
| Glycetin | −7.0 | −5.1 |
| Myricetin | −6.9 | −6.5 |
| Ferulic acid | −5.3 | −5.2 |
| Daidzin | −6.6 | −4.2 |
| p-coumaric acid | −5.5 | −5.0 |
| Caffeic acid | −5.7 | −5.2 |
| Rosmarinic acid | −5.9 | −6.8 |
| Kojic acid | −5.5 | - |
Figure 5Molecular docking diagram for rutin interaction with the catalytic site of tyrosinase. Results represent the mean ± SD of at least two independent experiments.